A murine model of Candida glabrata vaginitis shows no evidence of an inflammatory immunopathogenic response

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Nash, Evelyn E ^a,c   Peters, Brian M ^b,d   Lilly, Elizabeth A ^b   Noverr, Mairi C ^a,b   Fidel, Paul L ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; CALGRANULIN A; ESTROGEN; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOFILM; CANDIDA ALBICANS; CANDIDA GLABRATA; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; FEMALE; FUNGAL COLONIZATION; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY IMMUNOPATHOGENIC RESPONSE; INOCULATION; INSULIN DEPENDENT DIABETES MELLITUS; MIXED INFECTION; MOUSE; NEUTROPHIL CHEMOTAXIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGEN LOAD; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; VAGINA CANDIDIASIS; ANIMAL; COMPLICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY;

ANIMALS; BIOFILMS; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; MICE;

EID: 84959219564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147969     Document Type: Article

References (41)

1. Sobel JD. Vaginitis. N Engl J Med. 1997; 337(26):1896-903. PMID: 9407158
2. Sobel JD. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin Infect Dis. 1992; 14 Suppl 1:S148-53. PMID: 1562688
3. Fidel PL Jr., Barousse M, Espinosa T, Ficarra M, Sturtevant J, Martin DH, et al. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun. 2004; 72(5):2939-46. PMID: 15102806
4. Yano J, Noverr MC, Fidel PL Jr. Cytokines in the host response to Candida vaginitis: Identifying a role for non-classical immune mediators, S100alarmins. Cytokine. 2012; 58(1):118-28. doi: 10.1016/j.cyto. 2011.11.021 PMID: 22182685
5. Yano J, Lilly E, Barousse M, Fidel PL Jr. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis. Infect Immun. 2010; 78 (12):5126-37. doi: 10.1128/IAI.00388-10 PMID: 20823201
6. Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL Jr., Noverr MC. Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida albicans vaginitis. Infect Immun. 2014; 82(2):532-43. doi: 10.1128/IAI.01417-13 PMID: 24478069
7. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 1985; 152:924-35. PMID: 3895958
8. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005; 43 (5):2155-62. PMID: 15872235
9. Holland J, Young ML, Lee O, S CAC. Vulvovaginal carriage of yeasts otherthan Candida albicans. Sex Transm Infect. 2003; 79(3):249-50. PMID: 12794215
10. Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, et al. An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol ReprodBiol. 2003; 110(1):66-72. PMID: 12932875
11. de Leon EM, Jacober SJ, Sobel JD, Foxman B. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis. 2002; 2:1. PMID: 11835694
12. Nyirjesy P, Sobel JD. Genital mycotic infections in patients with diabetes. Postgrad Med. 2013; 125 (3):33-46. doi: 10.3810/pgm.2013.05.2650 PMID: 23748505
13. Fidel PL Jr., Vazquez JA, Sobel JD. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev. 1999; 12(1):80-96. PMID: 9880475
14. Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic agents against pathogenic vaginal yeast isolates. J Med Vet Mycol. 1994; 32(4):267-74. PMID: 7983571
15. Fidel PL Jr., Cutright JL, Tait L, Sobel JD. A murine model of Candida glabrata vaginitis. J Infect Dis. 1996; 173(2):425-31. PMID: 8568305
16. Black CA, Eyers FM, Dunkley ML, Clancy RL, Beagley KW. Major histocompatibility haplotype does not impact the course of experimentally induced murine vaginal candidiasis. LabAnim Sci. 1999; 49 (6):668-72. PMID: 10638507
17. Fidel PL Jr., Cutright JL, Sobel JD. Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infections. Infect Immun. 1995; 63(10):4191-4. PMID: 7558342
18. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol. 2006; 9(4):340-5. PMID: 16815078
19. Seneviratne CJ, Silva WJ, Jin LJ, Samaranayake YH, Samaranayake LP. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms. Arch Oral Biol. 2009; 54(11):1052-60. doi: 10.1016/j.archoralbio.2009.08.002 PMID: 19712926
20. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL Jr., Noverr MC. Candida albicans forms biofilms on the vaginal mucosa. Microbiology. 2010; 156:3635-44. doi: 10.1099/mic.0.039354-0 PMID: 20705667
21. Mahmoudi Rad M, Zafarghandi A, AmelZabihi M, Tavallaee M, Mirdamadi Y. Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR. Infect Dis Obstet Gynecol. 2012; 2012:872169. doi: 10.1155/2012/872169 PMID: 22791958
22. Sweet RL, Gibbs RS. Infectious Vulvovaginitis. In: Sweet RL, Gibbs RS, editors. Infectious Diseases of the Female Genital Tract. 5th ed: Lippincott Williams &Wilkins; 2009. p. 199-202.
23. Fidel PL Jr., Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev. 1996; 9(3):335-48. PMID: 8809464
24. Gonzalez GM, Elizondo M, Garza-Gonzalez E, Gonzalez JG. Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis. Mycoses. 2011; 54(2):119-22. doi: 10.1111/j. 1439-0507.2009.01775.x PMID: 19811615
25. Kasper L, Seider K, Hube B. Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence. FEMSYeast Res. 2015; 15(5):fov042. doi: 10.1093/femsyr/fov042 PMID: 26066553
26. Saavedra M, Taylor B, Lukacs N, Fidel PL Jr. Local production of chemokines during experimental vaginal candidiasis. Infect Immun. 1999; 67(11):5820-6. PMID: 10531235
27. Blankenship JR, Mitchell AP. How to build a biofilm: a fungal perspective. CurrOpin Microbiol. 2006; 9 (6):588-94. PMID: 17055772
28. Ramage G, Martinez JP, Lopez-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006; 6(7):979-86. PMID: 17042747
29. Dongari-Bagtzoglou A, Kashleva H, Dwivedi P, Diaz P, Vasilakos J. Characterization of mucosal Candida albicans biofilms. PLoSOne. 2009; 4(11):e7967. doi: 10.1371/journal.pone.0007967 PMID: 19956771
30. Kucharikova S, Tournu H, Lagrou K, Van Dijck P, Bujdakova H. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin andanidulafungin. J Med Microbiol. 2011; 60(Pt9):1261-9. doi: 10.1099/jmm.0.032037-0 PMID: 21566087
31. Silva S, Henriques M, Martins A, Oliveira R, Williams D, Azeredo J. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol. 2009; 47(7):681-9. doi: 10.3109/13693780802549594 PMID: 19888800
32. Hawser SP, Douglas LJ. Biofilm formation by Candida species on the surface of catheter materials in vitro. Infect Immun. 1994; 62(3):915-21. PMID: 8112864
33. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001; 183(18):5385-94. PMID: 11514524
34. Nobile CJ, Nett JE, Andes DR, Mitchell AP. Function of Candida albicans adhesin Hwp1 in biofilm formation. Eukaryot Cell. 2006; 5(10):1604-10. PMID: 17030992
35. Diaz PI, Xie Z, Sobue T, Thompson A, Biyikoglu B, Ricker A, et al. Synergistic interaction between Candida albicans and commensal oral Streptococci in a novel in vitro mucosal model. Infect Immun. 2012; 80(2):620-32. doi: 10.1128/IAI.05896-11 PMID: 22104105
36. Levison ME, Pitsakis PG. Susceptibility to experimental Candida albicans urinary tract infection in the rat. J Infect Dis. 1987; 155(5):841-6. PMID: 3549921
37. Azoulay E, Timsit JF, Tafflet M, de Lassence A, Darmon M, Zahar JR, et al. Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. Chest. 2006; 129 (1):110-7. PMID: 16424420
38. Peters BM, Noverr MC. Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity. Infect Immun. 2013; 81(6):2178-89. doi: 10.1128/IAI.00265-13 PMID: 23545303
39. Silva S, Henriques M, Hayes A, Oliveira R, Azeredo J, Williams DW. Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med. 2011; 40(5):421-7. doi: 10.1111/j. 1600-0714.2010.00981.x PMID: 21158929
40. Alves CT, Wei XQ, Silva S, Azeredo J, Henriques M, Williams DW. Candida albicans promotes invasion and colonisation of Candida glabrata in a reconstituted human vaginal epithelium. J Infect. 2014; 69 (4):396-407. doi: 10.1016/j.jinf.2014.06.002 PMID: 24924556
41. Brunke S, Hube B. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol. 2013; 15(5):701-8. doi: 10.1111/cmi.12091 PMID: 23253282